{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:09:07Z","timestamp":1791288547896,"version":"4.3.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00432-022-03982-7","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T19:03:26Z","timestamp":1647889406000},"page":"1115-1122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Characteristics and survival of primary vaginal malignancy: an analysis of the German nationwide cancer registry data"],"prefix":"10.1007","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5068-3933","authenticated-orcid":false,"given":"Dirk Michael","family":"Forner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,21]]},"reference":[{"issue":"Suppl 2","key":"3982_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/ijgo.12610","volume":"143","author":"TS Adams","year":"2018","unstructured":"Adams TS, Cuello MA (2018) Cancer of the vagina. Int J Gynaecol Obstet 143(Suppl 2):14\u201321","journal-title":"Int J Gynaecol Obstet"},{"key":"3982_CR2","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1016\/j.ejca.2014.07.018","volume":"50","author":"L Alemany","year":"2014","unstructured":"Alemany L, Saunier M, Tinoco L et al (2014) Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples. Eur J Cancer 50:2846\u20132854","journal-title":"Eur J Cancer"},{"key":"3982_CR3","unstructured":"American Joint Committee on Cancer. Vagina. In: AJCC Cancer Staging Manual, 8th ed. New York, NY: Springer; 2017:641\u201347."},{"key":"3982_CR4","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.ygyno.2020.05.683","volume":"158","author":"HK Bertoli","year":"2020","unstructured":"Bertoli HK, Baandrup L, Aalborg GL, Kjaer AK, Thomsen LT, Kjaer SK (2020) Time trends in the incidence and survival of vaginal squamous cell carcinoma and high-grade vaginal intraepithelial neoplasia in Denmark - a nationwide population-based study. Gynecol Oncol 158:734\u2013739","journal-title":"Gynecol Oncol"},{"key":"3982_CR5","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394\u2013424 (Erratum in: CA Cancer J Clin. 2020;70:313.)","journal-title":"CA Cancer J Clin."},{"key":"3982_CR6","doi-asserted-by":"publisher","first-page":"100687","DOI":"10.1016\/j.currproblcancer.2020.100687","volume":"45","author":"D Cao","year":"2021","unstructured":"Cao D, Wu D, Xu Y (2021) Vaginal intraepithelial neoplasia in patients after total hysterectomy. Curr Probl Cancer. 45:100687","journal-title":"Curr Probl Cancer."},{"key":"3982_CR7","doi-asserted-by":"publisher","unstructured":"Centre for Cancer Registry Data at the Robert Koch Institute: Database query with estimates of the incidence, prevalence and survival of cancer in Germany based on epidemiological state cancer registry data (DOI: https:\/\/doi.org\/10.18444\/5.03.01.0005.0015.0002)","DOI":"10.18444\/5.03.01.0005.0015.0002"},{"key":"3982_CR8","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/0360-3016(95)02394-1","volume":"35","author":"V Chyle","year":"1996","unstructured":"Chyle V, Zagars GK, Wheeler JA, Wharton JT, Delclos L (1996) Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors. Int J Radiat Oncol Biol Phys 35:891\u2013905","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3982_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1006\/gyno.2001.6502","volume":"84","author":"JR Daling","year":"2002","unstructured":"Daling JR, Madeleine MM, Schwartz SM et al (2002) A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 84:263\u2013270","journal-title":"Gynecol Oncol"},{"key":"3982_CR10","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.critrevonc.2011.04.004","volume":"81","author":"V Di Donato","year":"2012","unstructured":"Di Donato V, Bellati F, Fischetti M, Plotti F, Perniola G, Panici PB (2012) Vaginal cancer. Crit Rev Oncol Hematol 81:286\u2013295","journal-title":"Crit Rev Oncol Hematol"},{"key":"3982_CR11","unstructured":"Diagnostics, therapy and follow-up care of vaginal cancer and its precursors. Guideline of the DGGG and OEGGG (AWMF 032\/42 Oct. 2018 http:\/\/www.awmf.org\/leitlinien\/detail\/ll\/032-042.html"},{"key":"3982_CR12","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1200\/JCO.2016.71.4543","volume":"35","author":"RMF Ebisch","year":"2017","unstructured":"Ebisch RMF, Rutten DWE, IntHout J et al (2017) Long-lasting increased risk of human papillomavirus-related carcinomas and premalignancies after cervical intraepithelial neoplasia grade 3: a population-based cohort study. J Clin Oncol 35:2542\u20132550","journal-title":"J Clin Oncol"},{"key":"3982_CR13","first-page":"101","volume":"6","author":"F Ederer","year":"1961","unstructured":"Ederer F, Astell LM, Cutler SJ (1961) The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 6:101\u2013121","journal-title":"Natl Cancer Inst Monogr"},{"key":"3982_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2013.05.028","author":"K Geiss","year":"2013","unstructured":"Geiss K, Meyer M (2013) A Windows application for computing standardized mortality ratios and standardized incidence ratios in cohort studies based on calculation of exact person-years at risk. Comput Methods Programs Biomed. https:\/\/doi.org\/10.1016\/j.cmpb.2013.05.028","journal-title":"Comput Methods Programs Biomed"},{"key":"3982_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/LGT.0b013e3182800ee2","volume":"17","author":"CC Gunderson","year":"2013","unstructured":"Gunderson CC, Nugent EK, Yunker AC et al (2013) Vaginal cancer: the experience from 2 large academic centers during a 15-year period. J Low Genit Tract Dis. 17:409\u201313","journal-title":"J Low Genit Tract Dis."},{"key":"3982_CR16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00404-015-3835-6","volume":"293","author":"M Jentschke","year":"2016","unstructured":"Jentschke M, Hoffmeister V, Soergel P, Hillemanns P (2016) Clinical presentation, treatment and outcome of vaginal intraepithelial neoplasia. Arch Gynecol Obstet 293:415\u2013419","journal-title":"Arch Gynecol Obstet"},{"key":"3982_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/0090-8258(91)90076-H","volume":"40","author":"H Kucera","year":"1991","unstructured":"Kucera H, Vavra N (1991) Radiation management of primary carcinoma of the vagina: clinical and histopathological variables associated with survival. Gynecol Oncol 40:12\u201316","journal-title":"Gynecol Oncol"},{"key":"3982_CR18","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0002-9378(12)90738-3","volume":"165","author":"MJ Merino","year":"1991","unstructured":"Merino MJ (1991) Vaginal cancer: the role of infectious and environmental factors. Am J Obstet Gynecol 165:1255\u20131262","journal-title":"Am J Obstet Gynecol"},{"key":"3982_CR19","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/0360-3016(88)90222-2","volume":"15","author":"CA Perez","year":"1988","unstructured":"Perez CA, Camel HM, Galakatos AE et al (1988) Definitive irradiation in carcinoma of the vagina: long-term evaluation and results. Int J Radiat Oncol Biol Phys 15:1283\u20131290","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3982_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0360-3016(98)00530-6","volume":"44","author":"CA Perez","year":"1999","unstructured":"Perez CA, Grigsby PW, Garipagaoglu M et al (1999) Factors affecting longterm outcome of irradiation in carcinoma of the vagina. Int J Radiat Oncol Biol Phys 44:37\u201345","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3982_CR21","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.4103\/jcrt.JCRT_893_15","volume":"15","author":"S Puri","year":"2019","unstructured":"Puri S, Asotra S (2019) Primary vaginal malignant melanoma: a rare entity with review of literature. J Cancer Res Ther 15:1392\u20131394","journal-title":"J Cancer Res Ther"},{"key":"3982_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.brachy.2020.08.020","volume":"20","author":"LB Reshko","year":"2021","unstructured":"Reshko LB, Gaskins JT, Metzinger DS, Todd SL, Eldredge-Hindy HB, Silva SR (2021) The impact of brachytherapy boost and radiotherapy treatment duration on survival in patients with vaginal cancer treated with definitive chemoradiation. Brachytherapy 20:75\u201384","journal-title":"Brachytherapy"},{"key":"3982_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69:7\u201334","journal-title":"CA Cancer J Clin"},{"key":"3982_CR24","first-page":"818","volume":"20","author":"F Sopracordevole","year":"2016","unstructured":"Sopracordevole F, Barbero M, Clemente N et al (2016) High-grade vaginal intraepithelial neoplasia and risk of progression to vaginal cancer: a multicentre study of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV). Eur Rev Med Pharmacol Sci 20:818\u2013824","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3982_CR25","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1002\/ijc.30275","volume":"139","author":"K Tainio","year":"2016","unstructured":"Tainio K, Jakobsson M, Louvanto K et al (2016) Randomised trial on treatment of vaginal intraepithelial neoplasia-Imiquimod, laser vaporisation and expectant management. Int J Cancer 139:2353\u20132358","journal-title":"Int J Cancer"},{"key":"3982_CR26","unstructured":"United States Cancer Statistics: Data Visualizations, Centers for Disease Control and Prevention (CDC), https:\/\/gis.cdc.gov\/Cancer\/USCS\/DataViz.html Accessed 25 April 2021"},{"key":"3982_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1006\/gyno.1996.0004","volume":"60","author":"K Urba\u0144ski","year":"1996","unstructured":"Urba\u0144ski K, Kojs Z, Reinfuss M, Fabisiak W (1996) Primary invasive vaginal carcinoma treated with radiotherapy: analysis of prognostic factors. Gynecol Oncol 60:16\u201321","journal-title":"Gynecol Oncol"},{"key":"3982_CR28","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1002\/cncr.23757","volume":"113","author":"X Wu","year":"2008","unstructured":"Wu X, Matanoski G, Chen VW, Saraiya M, Coughlin SS, King JB, Tao XG et al (2008) Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States. Cancer 113:2873\u201382","journal-title":"Cancer"},{"key":"3982_CR29","doi-asserted-by":"publisher","first-page":"e7751","DOI":"10.1097\/MD.0000000000007751","volume":"96","author":"A Yagi","year":"2017","unstructured":"Yagi A, Ueda Y, Kakuda M et al (2017) Descriptive epidemiological study of vaginal cancer using data from the Osaka Japan population-based cancer registry: Long-term analysis from a clinical viewpoint. Medicine 96:e7751","journal-title":"Medicine"},{"key":"3982_CR30","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ygyno.2020.08.036","volume":"159","author":"J Yang","year":"2020","unstructured":"Yang J, Delara R, Magrina J et al (2020) Management and outcomes of primary vaginal cancer. Gynecol Oncol 159:456\u2013463","journal-title":"Gynecol Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-03982-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-022-03982-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-03982-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T10:11:37Z","timestamp":1677838297000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-022-03982-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,21]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["3982"],"URL":"https:\/\/doi.org\/10.1007\/s00432-022-03982-7","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,21]]},"assertion":[{"value":"23 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The use of the data for this study was reviewed and approved by the Scientific Board of the German Centre for Cancer Registry Data, Robert Koch Institute.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}